Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch.

Newsroom


The Assistance Fund Announces New Hereditary Amyloidosis Financial Assistance Program

The Assistance Fund Announces New Hereditary Amyloidosis Financial Assistance Program

The Assistance Fund, an independent charitable patient assistance foundation, recently launched a new fund to support hereditary amyloidosis patients. This type of amyloidosis is one of the systemic amyloidosis diseases that are caused by inheriting a gene mutation.

“Finally, patients have hope for treating this disease,” said Mary O’Donnell, President and CEO of the Amyloidosis Foundation. “The Assistance Fund’s financial assistance program for hereditary (hATTR) amyloidosis will provide extremely important support for patients who may otherwise be unable to seek treatment due to high out-of-pocket costs.”

They provide financial assistance for medication copays, health insurance premiums, and basic healthcare needs to patients with certain disease types.

For more information, call (855) 512-2801.

Read the entire press release here.

To apply for assistance, click here.